Activation of central cannabinoid type 2 receptors, but not on peripheral immune cells, is required for endocannabinoid-mediated neuroprotection in Parkinson's disease

1. Ayerra,L.
2. Abellanas,M.A.
3. Vidaurre,C.
4. Basurco,L.
5. Tavira,A.
6. Luquin,E.
7. Clavero,P.
8. Mengual,E.
9. Collantes,M.
10. Peñuelas,I.
11. de Martin-Esteban,S.R.
12. Grether,U.
13. Hillard,C.J.
14. Romero,J.
15. Hervás-Stubbs,S.
16. Aymerich,M.S.

Export

Export ×

MLA

modern-language-association

APA

apa

Chicago

chicago-fullnote-bibliography

Harvard

harvard-cite-them-right

Vancouver

vancouver-author-date

---

RIS BibTex

Export ×

This document cannot be exported because it belongs to another portal.

Full text

lock_openFull text externo

DOI: 10.1016/J.BBI.2025.04.037 GOOGLE SCHOLAR lock_openOpen access editor

Data source: Scopus